Notify me when Tikvah Management LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 23 | $368,073,075 | +$10,964,286 | -$28,818,716 | -$17,854,430 | AMZN, GOOGL, RHLD, BIO, CMPO | 13F-HR | 13 Feb 2026, 15:41 |
| Q3 2025 | 23 | $330,648,645 | +$8,049,511 | -$35,435,022 | -$27,385,511 | AMZN, GOOGL, CMPO, BIO, SPY | 13F-HR | 14 Nov 2025, 12:38 |
| Q2 2025 | 22 | $303,076,671 | +$956,100 | -$22,516,162 | -$21,560,062 | AMZN, GOOGL, CMPO, BIO, SPY | 13F-HR | 13 Aug 2025, 18:16 |
| Q1 2025 | 24 | $287,798,564 | +$11,953,533 | -$14,236,620 | -$2,283,087 | AMZN, GOOGL, BIO, CMPO, SPY | 13F-HR | 13 May 2025, 14:26 |
| Q4 2024 | 24 | $367,153,477 | +$14,389,283 | -$6,273,121 | +$8,116,162 | AMZN, GOOGL, BIO, CMPO, PCOR | 13F-HR | 12 Feb 2025, 17:52 |
| Q3 2024 | 24 | $322,609,975 | +$986,400 | -$11,221,157 | -$10,234,757 | AMZN, BIO, GOOGL, CMPO, SPY | 13F-HR | 12 Nov 2024, 12:23 |
| Q2 2024 | 25 | $283,311,747 | +$7,029,785 | -$2,155,854 | +$4,873,931 | AMZN, GOOGL, BIO, PCOR, GOOG | 13F-HR | 12 Aug 2024, 13:13 |
| Q1 2024 | 23 | $319,210,768 | +$25,296,901 | -$20,704,543 | +$4,592,358 | AMZN, BIO, GOOGL, PCOR, SPY | 13F-HR | 14 May 2024, 17:32 |
| Q4 2023 | 22 | $291,388,904 | +$19,197,494 | -$24,806,271 | -$5,608,777 | AMZN, BIO, GOOGL, PCOR, AVDX | 13F-HR | 13 Feb 2024, 18:29 |
| Q3 2023 | 22 | $278,804,604 | +$1,018,322 | -$7,490,841 | -$6,472,519 | AMZN, BIO, GOOGL, AVDX, PCOR | 13F-HR | 13 Nov 2023, 18:36 |
| Q2 2023 | 22 | $294,018,253 | +$30,687,397 | -$3,736,543 | +$26,950,854 | AMZN, BIO, GOOGL, AVDX, PCOR | 13F-HR | 11 Aug 2023, 14:41 |
| Q1 2023 | 23 | $243,332,533 | +$12,567,622 | $0 | +$12,567,622 | BIO, AMZN, GOOGL, AVDX, PCOR | 13F-HR | 10 May 2023, 11:28 |
| Q4 2022 | 23 | $209,447,898 | +$13,581,899 | -$10,222,001 | +$3,359,898 | BIO, AMZN, AVDX, GOOGL, SPY | 13F-HR | 06 Feb 2023, 14:47 |
| Q3 2022 | 24 | $216,283,000 | +$38,548,498 | $0 | +$38,548,498 | AMZN, BIO, GOOGL, AVDX, SPY | 13F-HR | 14 Nov 2022, 13:04 |
| Q2 2022 | 24 | $232,066,000 | +$45,046,041 | -$399,096 | +$44,646,945 | BIO, AMZN, GOOGL, AVDX, SPY | 13F-HR | 12 Aug 2022, 17:56 |
| Q1 2022 | 23 | $312,752,000 | +$80,735,509 | -$78,211,000 | +$2,524,509 | AMZN, BIO, GOOGL, AVDX, SLGC | 13F-HR | 16 May 2022, 14:13 |
| Q4 2021 | 21 | $358,553,000 | +$72,740,350 | -$76,578,369 | -$3,838,019 | BIOB, AMZN, GOOGL, AVDX, SPY | 13F-HR | 14 Feb 2022, 10:46 |
| Q3 2021 | 21 | $369,804,055 | +$45,849,036 | -$50,541,327 | -$4,692,291 | BIOB, AMZN, INOV, GOOGL, SMRT | 13F-HR | 12 Nov 2021, 11:30 |
| Q2 2021 | 18 | $362,218,000 | +$83,006,000 | -$125,028,853 | -$42,022,853 | AMZN, BIOB, QADA, INOV, GOOGL | 13F-HR | 13 Aug 2021, 17:40 |
| Q1 2021 | 16 | $356,506,000 | +$1,636,159 | -$25,212,061 | -$23,575,902 | BIO, QADA, AMZN, INOV, GOOGL | 13F-HR | 14 May 2021, 17:36 |
| Q4 2020 | 17 | $358,794,000 | +$3,146,024 | -$8,542,636 | -$5,396,612 | BIO, AMZN, QADA, INOV, GOOGL | 13F-HR | 16 Feb 2021, 21:39 |
| Q3 2020 | 17 | $323,832,000 | +$2,760,809 | -$47,230,278 | -$44,469,469 | BIO, AMZN, QADA, INOV, FARO | 13F-HR | 16 Nov 2020, 17:03 |
| Q2 2020 | 19 | $327,009,000 | +$15,661,385 | $0 | +$15,661,385 | AMZN, BIO, QADA, INOV, FARO | 13F-HR | 14 Aug 2020, 09:00 |
| Q1 2020 | 17 | $252,656,000 | +$2,194,099 | -$86,954,237 | -$84,760,138 | AMZN, BIO, QADA, INOV, FARO | 13F-HR | 14 May 2020, 17:54 |
| Q4 2019 | 18 | $386,589,000 | +$3,680,164 | -$3,073,000 | +$607,164 | BIO, QADA, AMZN, INOV, GOOG | 13F-HR | 13 Feb 2020, 13:23 |
| Q3 2019 | 19 | $358,645,000 | +$9,578,760 | -$4,639,398 | +$4,939,362 | BIO, QADA, AMZN, INOV, GOOG | 13F-HR | 13 Nov 2019, 13:57 |
| Q2 2019 | 19 | $352,442,000 | +$41,996,695 | -$1,874,000 | +$40,122,695 | AMZN, BIO, QADA, FARO, INOV | 13F-HR | 13 Aug 2019, 09:40 |
| Q1 2019 | 19 | $301,225,000 | +$8,514,258 | -$20,903,026 | -$12,388,768 | AMZN, BIO, QADA, INOV, FARO | 13F-HR | 14 May 2019, 15:52 |
| Q4 2018 | 20 | $281,837,000 | +$27,170,463 | -$22,679,042 | +$4,491,421 | AMZN, QADA, BIO, INOV, NATI | 13F-HR | 13 Feb 2019, 13:38 |
| Q3 2018 | 19 | $334,614,000 | +$5,862,000 | -$22,331,166 | -$16,469,166 | QADA, AMZN, BIO, NATI, FARO | 13F-HR | 13 Nov 2018, 16:30 |
| Q2 2018 | 18 | $318,619,000 | $0 | -$20,042,024 | -$20,042,024 | QADA, AMZN, BIO, NATI, FARO | 13F-HR | 14 Aug 2018, 12:16 |
| Q1 2018 | 18 | $325,476,000 | +$61,382,713 | $0 | +$61,382,713 | AMZN, QADA, BIO, INDA, NATI | 13F-HR | 14 May 2018, 18:39 |
| Q4 2017 | 18 | $248,537,000 | +$1,824,037 | -$8,434,216 | -$6,610,179 | QADA, BIO, AMZN, NATI, BRKA | 13F-HR | 13 Feb 2018, 18:15 |
| Q3 2017 | 19 | $235,922,000 | +$15,326,641 | $0 | +$15,326,641 | QADA, BIO, AMZN, NATI, INOV | 13F-HR | 13 Nov 2017, 19:11 |
| Q2 2017 | 18 | $212,484,000 | +$3,987,431 | -$1,936 | +$3,985,495 | QADA, BIO, AMZN, NATI, BRKA | 13F-HR | 11 Aug 2017, 18:01 |
| Q1 2017 | 17 | $190,611,000 | +$10,323,475 | -$33,930,497 | -$23,607,022 | BIO, QADA, AMZN, BRKA, NATI | 13F-HR | 12 May 2017, 13:12 |
| Q4 2016 | 18 | $203,479,000 | +$6,111,439 | -$7,706,627 | -$1,595,188 | QADA, BIO, SPY, AMZN, BRKA | 13F-HR | 13 Feb 2017, 11:35 |
| Q3 2016 | 18 | $191,597,000 | +$18,665,000 | -$12,495,000 | +$6,170,000 | QADA, BIO, AMZN, SPY, NATI | 13F-HR | 14 Nov 2016, 09:44 |
| Q2 2016 | 17 | $170,819,000 | +$2,308,000 | -$10,694,935 | -$8,386,935 | SPY, QADA, BIO, AMZN, NATI | 13F-HR | 15 Aug 2016, 11:04 |
| Q1 2016 | 16 | $179,932,000 | +$12,738,469 | -$18,685,905 | -$5,947,436 | QADA, SPY, NATI, BIO, AMZN | 13F-HR | 16 May 2016, 11:12 |
| Q4 2015 | 18 | $190,813,000 | +$32,867,263 | -$24,980,000 | +$7,887,263 | SPY, QADA, NATI, BIO, AMZN | 13F-HR | 16 Feb 2016, 10:57 |
| Q3 2015 | 19 | $179,566,000 | +$2,863,941 | -$4,618,249 | -$1,754,308 | QADA, SPY, NATI, BIO, AMZN | 13F-HR | 16 Nov 2015, 09:58 |
| Q2 2015 | 19 | $188,537,000 | +$7,068,515 | -$4,888,960 | +$2,179,555 | SPY, QADA, NATI, BIO, NICE | 13F-HR | 14 Aug 2015, 10:57 |
| Q1 2015 | 19 | $181,146,000 | +$35,115,983 | -$10,416,193 | +$24,699,790 | SPY, QADA, NATI, BRKA, NICE | 13F-HR | 15 May 2015, 11:00 |
| Q4 2014 | 16 | $153,154,000 | +$15,974,501 | -$13,984,892 | +$1,989,609 | SPY, BRKA, NATI, NICE, BIO | 13F-HR | 17 Feb 2015, 10:06 |
| Q3 2014 | 17 | $142,007,000 | +$939,120 | -$159,253 | +$779,867 | SPY, BRKA, NATI, BIOB, BAC | Restatement | 21 Nov 2014, 09:43 |
| Q2 2014 | 17 | $142,048,000 | +$21,494,346 | -$13,783,224 | +$7,711,122 | SPY, NATI, BRKA, BIOB, NICE | 13F-HR | 14 Aug 2014, 11:03 |
| Q1 2014 | 17 | $135,184,000 | $0 | $0 | $0 | SPY, BRKA, BIO, NATI, BAC | 13F-HR | 15 May 2014, 11:00 |